These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 23075911)
1. Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators. Tovmasyan A; Sheng H; Weitner T; Arulpragasam A; Lu M; Warner DS; Vujaskovic Z; Spasojevic I; Batinic-Haberle I Med Princ Pract; 2013; 22(2):103-30. PubMed ID: 23075911 [TBL] [Abstract][Full Text] [Related]
2. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics. Batinic-Haberle I; Rajic Z; Tovmasyan A; Reboucas JS; Ye X; Leong KW; Dewhirst MW; Vujaskovic Z; Benov L; Spasojevic I Free Radic Biol Med; 2011 Sep; 51(5):1035-53. PubMed ID: 21616142 [TBL] [Abstract][Full Text] [Related]
3. An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins--From superoxide dismutation to H2O2-driven pathways. Batinic-Haberle I; Tovmasyan A; Spasojevic I Redox Biol; 2015 Aug; 5():43-65. PubMed ID: 25827425 [TBL] [Abstract][Full Text] [Related]
4. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+). Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z Redox Biol; 2014; 2():400-10. PubMed ID: 24624330 [TBL] [Abstract][Full Text] [Related]
5. Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents. Tovmasyan A; Carballal S; Ghazaryan R; Melikyan L; Weitner T; Maia CG; Reboucas JS; Radi R; Spasojevic I; Benov L; Batinic-Haberle I Inorg Chem; 2014 Nov; 53(21):11467-83. PubMed ID: 25333724 [TBL] [Abstract][Full Text] [Related]
6. Impact of electrostatics in redox modulation of oxidative stress by Mn porphyrins: protection of SOD-deficient Escherichia coli via alternative mechanism where Mn porphyrin acts as a Mn carrier. Rebouças JS; DeFreitas-Silva G; Spasojević I; Idemori YM; Benov L; Batinić-Haberle I Free Radic Biol Med; 2008 Jul; 45(2):201-10. PubMed ID: 18457677 [TBL] [Abstract][Full Text] [Related]
7. Mn Porphyrin-Based Redox-Active Drugs: Differential Effects as Cancer Therapeutics and Protectors of Normal Tissue Against Oxidative Injury. Batinic-Haberle I; Tovmasyan A; Spasojevic I Antioxid Redox Signal; 2018 Dec; 29(16):1691-1724. PubMed ID: 29926755 [TBL] [Abstract][Full Text] [Related]
8. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins. Tovmasyan AG; Rajic Z; Spasojevic I; Reboucas JS; Chen X; Salvemini D; Sheng H; Warner DS; Benov L; Batinic-Haberle I Dalton Trans; 2011 Apr; 40(16):4111-21. PubMed ID: 21384047 [TBL] [Abstract][Full Text] [Related]
9. Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities. Batinic-Haberle I; Spasojevic I; Tse HM; Tovmasyan A; Rajic Z; St Clair DK; Vujaskovic Z; Dewhirst MW; Piganelli JD Amino Acids; 2012 Jan; 42(1):95-113. PubMed ID: 20473774 [TBL] [Abstract][Full Text] [Related]
16. A combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon. Batinic-Haberle I; Rajic Z; Benov L Anticancer Agents Med Chem; 2011 May; 11(4):329-40. PubMed ID: 21355843 [TBL] [Abstract][Full Text] [Related]
17. Manganese porphyrin redox state in endothelial cells: Resonance Raman studies and implications for antioxidant protection towards peroxynitrite. Carballal S; Valez V; Alvarez-Paggi D; Tovmasyan A; Batinic-Haberle I; Ferrer-Sueta G; Murgida DH; Radi R Free Radic Biol Med; 2018 Oct; 126():379-392. PubMed ID: 30144631 [TBL] [Abstract][Full Text] [Related]
18. Differential coordination demands in Fe versus Mn water-soluble cationic metalloporphyrins translate into remarkably different aqueous redox chemistry and biology. Tovmasyan A; Weitner T; Sheng H; Lu M; Rajic Z; Warner DS; Spasojevic I; Reboucas JS; Benov L; Batinic-Haberle I Inorg Chem; 2013 May; 52(10):5677-91. PubMed ID: 23646875 [TBL] [Abstract][Full Text] [Related]
19. Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP Rajic Z; Tovmasyan A; de Santana OL; Peixoto IN; Spasojevic I; do Monte SA; Ventura E; Rebouças JS; Batinic-Haberle I J Inorg Biochem; 2017 Apr; 169():50-60. PubMed ID: 28131001 [TBL] [Abstract][Full Text] [Related]
20. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors. Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]